In short
Podcast Summary: CNBC's "Fast Money" Episode - Rough Road Ahead for Stocks? And an Under-the-Radar Winner in the Weight Loss Boom (9/25/23)
Podcast Description: Hosted by Melissa Lee, "Fast Money" features a roundtable of elite traders who dissect the day's news and deliver actionable insights for investors.
---
Episode Overview In this episode, the discussion revolves around the implications of rising treasury yields, a steepening yield curve, oil price dynamics, and the booming weight loss drug market. Key insights are provided by traders and the CEO of Jacobs Solutions.
Key Topics Covered
- Rising Treasury Yields
- The yield on 10-year treasuries surpassed 4.5%, marking the highest level since October 2007.
- Chris Verone from Strategas highlighted concerns regarding the relationship between short-term and long-term treasury yields, suggesting a potential rough period for equities ahead.
- Steepening Yield Curve
- Verone explained that while inverted yield curves are often cited as warning signs, it's the transition back to steepening that historically indicates trouble for equities.
- Previous instances of this bear steepening occurred before significant downturns in 1969-70 and 1973-74, suggesting current market vulnerabilities.
- Oil Prices
- Oil prices have surged nearly 30% this quarter, with comments from industry executives indicating that the rally may continue.
- Traders discussed strategies for capitalizing on this trend in the investment landscape.
- Weight Loss Drug Market
- The episode features an interview with Bob Pregata, CEO of Jacobs Solutions, who discussed his company's benefit from the rising demand for weight loss medications produced by Eli Lilly and Novo Nordisk.
- Jacobs Solutions holds a substantial market share in the life sciences sector, positioning the company well to capitalize on this growing market.
---
Key Takeaways
Economic and Market Implications
- Warning Signs: The current state of the yield curve and rising treasury yields signal potential risks for equity markets.
- Sector Rotation: There is a noticeable shift from cyclicals to defensives, indicating changing investor sentiments as the economic cycle progresses.
Insights from Traders
- Chris Verone's Perspective:
- The steepening yield curve could mean approaching financial difficulties for equities.
- Historical patterns suggest that the market may be nearing its peak, reinforced by current trends in consumer spending and corporate margins.
- General Market Sentiment:
- Concerns about consumer credit and the ability of corporations to pass on rising costs could hinder market performance.
- The recent performance of discretionary stocks and tech sectors, particularly underwhelming compared to energy and defensive stocks, reflects these challenges.
Jacobs Solutions and the Weight Loss Boom
- Growth Potential:
- Jacobs Solutions anticipates significant growth driven by the weight loss drug market, potentially doubling its advanced manufacturing business.
- Pregata highlighted the company’s robust backlog and its strategic positioning to adapt to ongoing demand in the biotech sector.
---
Final Insights
Investment Strategies
- Market Caution: Experts suggest being cautious about equity investments in a potentially peaking market, advocating for selective positioning in defensives and sectors benefiting from macroeconomic trends.
- Energy Focus: With oil prices on the rise, energy stocks are viewed favorably as they tend to perform well early in economic cycles.
Conclusion The episode serves as a critical reminder for investors to monitor macroeconomic indicators and market dynamics closely. The potential for a rough patch in equities looms, driven by rising yields and shifts in market leadership, while sectors like life sciences offer promising growth opportunities amid changing consumer health trends.
For more insights and updates, visit the [Fast Money website](http://fastmoney.cnbc.com).
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Transcript
Automatic transcript. May contain errors.0:01Live from the Nasdaq market side in the heart of New York City's Times Square. This is Fast money. Here's what's on tap tonight. A warning from the bond market. Ten-year yields crossing the key 4.5 % mark today for the first time since 2007. But it's a relationship with shorter-term treasuries that has one of our traders setting up red flags. While he says the yield curve is flashing big warning signs. Plus, crude reality is oil prices up nearly 30 % this quarter. And one top exec says the rally has only just begun. What it means for your investment and how you should play the move. And later, an under-the-radar winner in the weight loss drug craze.
0:35We'll talk to the CEO of a manufacturing company with close ties to both Eli Lilly and Novo Nordisk. Jacob Solutions, Bob Pregata, is on set tonight to detail how the company is benefiting from the boom in demand. I'm Melissa Lee coming to you live from Studio B at the NASDAQ on the desk tonight. Tim Seymour, Dan Nath, and Guy Dami. And our guest trader tonight, Chris Verone of Strategas, a Baird company. And we start off with that steepening of the yield curve. The 10 years rapid rise to 4.5 % and beyond has come much faster at a much faster pace than the two years climb over the past few months.
1:07And that's narrowed the spread between the two treasuries sharply. Since hitting a four-decade-plus low earlier the year, the gap has come in by nearly 50 basis points since July. Someone here tonight says that could set up for a very rough period in the equities. Chris is that person. What do you see? You know, what's funny about this business is people get all worked up about an inverted curve. But it's really not the inverted curve that gets you in trouble. It's when the curve begins to come out of inversion, when the curve actually starts to steepen. And I think the big story of the last three, four months is the steepening of twos and tens.
1:38Now, it's steepened in an odd way. This has been a bear steepener. So 10-year yields have backed up, even if twos have kind of hovered around five. It's a little unusual. You've only saw that twice historically, 1969, 1970, and 1973, 74. It was the signal you were approaching the tough part of the business cycle. And I think what's interesting, when you look at these steepeners historically, that move going from inverted back to positive has typically been the worst part of the equity cycle. So I just want to be mindful of what the signal here is. It tends to be a risk-off signal, particularly for leadership.
2:10And I think the big story the last four, five, six weeks is how you've seen cyclicality really start to falter and defensive showing some life. So when you say the worst part, like how bad was that period in the equity markets for those two periods of time? Yeah, I mean, that was the lead up to the recession in 69 and then 73, 74. So you're at the point where markets actually tend to be topping. The best part of the curve is actually when it's very, very steep and flattening. So there's misconceptions about the curve. It's when it's steepening from an inverted position, trouble has typically followed.
2:40And there's an argument that this kind of bear steepening, which is the long end getting higher, is somewhat bullish because the economy is not falling out of bed and you're not seeing at least the market start to price in the short end of the curve. The part about this that just is different and feels different is that some of this steepening is all coming from supply. It's all coming from some dysfunction around our government, possibly, but certainly around refunding, certainly around the dynamic of where I think the global interest rate pattern is going higher. And look at the dollar, by the way, the dollar, which today went up to that kiss, that one oh six level on the on the Dixie.
3:15You're basically, I think, breaking out through that March resistance. And you probably will test that. As someone that thought that the dollar was going to go lower, and I'm not alone, I think it's a crowded trade of people that have been, frankly, wrong about this dollar weakening. I think it's a very crowded trade that probably still will see people holding in there. But the dollar is painful for markets here, and I think that's going toe-in-toe with the Treasury market. The warning signs are there. I mean, Chris is right. The reason why people get exercised about an inverted yield curve is because they know at some point it's going to re-steepen.
3:45And to your point, the re-steepening is when things get dicey. and this bear re-steepening, again, not to get too wonky, it's happening in a very dramatic way. I mean, 10-year yields now through 4.5%. This is the highest we've seen in 16 years. The TLT closing below 90, not a good thing either. And you have to wonder, how long can the market hold in there? The S &P has held last August high, 43.30-ish. We've bounced off there a couple times. That's a good sign. The question is for how much longer. Yeah, it's interesting that Chris mentioned what this means for this stage of the economic cycle.
4:17And I'm just like two of my favorite bears on the street. Mike Wilson at Morgan Stanley. He's talking about just consumer and some of the data that they're tracking and what that means. And then Marco Kalanovic over at J.P. Morgan this morning, also in a no doubt, you know, just talking about corporate's ability to pass through this same kind of concept, pass through, you know, higher input costs and the like. And you just say to yourself, as it relates to the economy, you know, we have businesses that probably hit peak margins and, you know, really pass through as much as they can. And a consumer, from a credit standpoint, that just tapped at a point where rates have gone up so fast.
4:50And if you are like a lower wage earner and wages have, you know, at least the pace in which they're going up has decelerated a little bit. I just, you know, I'm just hard pressed to see all of this together is conducive for equities going much higher in the near term until there's a proper, you know, correction or so. And if you look at that equal weight S &P 500, it was about down 9 percent or so. So I think seeing down 10 % would be an interesting alarm bell with the VIX above 20 or something. We haven't gotten there yet, but it might get there, especially if we have a continuation of this move where the 10-year keeps going higher and we have that re-steepening.
5:24So we've always had this conversation about the steepening of the 10-year yield in the context of it makes tech, it makes biotech, all those sort of more speculative trades, longer duration trades, less attractive. So this is just happening in conjunction with what is going on with the yield curve? Yeah, I think so. And when you look at this last leg higher in yields, what's really been hit are the very marginal parts of the equity market. I mean, ARK is under 40. We've seen even what was hailed as good IPOs a week ago, ARM and Instacart, are back on their lows here. So the marginal parts of the market are quite weak.
6:00I do think it's interesting, Dan, on the margin point, right, margins under pressure, The things every company needs, people, money and energy have all gone up. The cost of all of those have all gone up. You know, we've done a lot of work looking at energy versus discretionary in this part of the cycle. Energy's dominance over consumer discretionary is a late cycle signal, not an early cycle one. Yeah. And if you look at the XLE, to me, we're possibly breaking out again. This is an area where if you look at it on the charts and there's there's it's not just about a linearity to the oil price. It really is the kind of guidance we're getting from these companies.
6:33I mean, Guy referenced the Chevron CEO last week. And the dynamics, I think, around their balance sheet are things that are going to continue to support that defensiveness. Defensiveness, staples, health care, which typically go along with energy here. I think they're getting interesting. I don't think it's time just yet. And again, I look at staples, which have drastically underperformed the S &P over the last six months, 16, 17, 18 percent. And back to that pricing power Dan was talking about and what companies can pass through. I think the best days of that, I think we've seen their best days on a two-year basis for a long time.
7:05Discretionary stocks, that's horrible. I mean, I'm looking at like Disney and Nike are down 30 % from this year's highs, okay? And then you look at a Starbucks down 20%. We've talked about these names. I mean, they're telling you something to both of those things I think we've talked about. A consumer that's a bit tapped at a time where all of those inputs are really weighing on margins. Again, I think the most vaunted parts of the market all year, discretionary and semis or tech, internally are actually the weakest. Only 40 % of discretionary above the 200 moving average. That's not a bull market reading there.
7:35We beat up on Target all the time, but it's a pretty decent indicator. Now, a lot of their problems are self-inflicted. 110 and change today. Lowest we've seen in many years in Target. Bounce late still. Not a particularly good day. The outperformance of Walmart vis-a-vis these dollar stores is not good. Massive double top in the SMH. We brought that up. And the XLE, I think we test the levels we saw, I think, in the summer of 2014, 100-ish dollars. And I think we break through. Energy still works in this environment. So when is the time to go short? If we're going to hit the hardest part, if we're going to, you know, if some of the leaders of the markets look weakest, when do you go short?
8:13I'm going to look at Dan because you have been known to short various areas of the market. Some have been paying trades. But is now the time? Well, I think we're losing some of the leadership. I mean, Tesla, did you see the way Tesla closed on Friday? And it was trading pretty weak today. You know, NVIDIA is down, you know, 16, 17 percent from those post earnings highs. And again, until they make new relative highs, like until they take out the ones I think you can I think you short the Nasdaq. I mean, like, so I hadn't done that in a while. I did it last week. The timing was OK this time. But, you know, I think those are going to be under pressure because I think if you look at the S &P 500, which, you know, those top 10 names make up a little more than 25 percent or so.
8:53I mean, they're still hanging in there. OK. You know what I mean? They definitely are. And Microsoft and Apple, you could consider heroic in terms of how they overcame that elevator trip down. But it's about risk reward. And to me, Apple's 150 before it's 200. And that risk reward is a dynamic doesn't mean Apple can't do a great job in buying back shares and actually growing earnings just through some of their capital markets dynamics. But I don't think that the mega cap tech stocks are going to hurt you here, even in a defensive market. But I get back to discretion. Look, I'm short Nike. I'm short Lulu.
9:25I think a lot of these names are going to continue to weaken up. Nike's had a big move lower. I think it can look this week is very interesting. I'm contemplating tactically. You know, how good does it get in this name? If you think about it, it's about 24 times on a forward. It's come in 20 percent off of that multiple on a forward basis. I think it can go lower. Yeah. What would you short here, Chris? I'm with Dan on this. I think what we've seen is the year to date tops for Apple, Microsoft, NVIDIA. They are oversold in the short term. I recognize that seasonality improves the next couple of weeks.
9:58I want to be a seller of those bounces. The 50-day moving averages on all those stocks are now, I think, very important resistance, not just for the remainder of the year, but into first quarter of next year. I'll answer that as well. Regional banks, I don't think they trade particularly. Megacap banks don't trade well. Bank of America, Citibank, Wells Fargo to a certain extent. But regional banks and the KRE not traded particularly well. I think they roll over, especially, look, you look at the Russell, the IWM. We topped out. Seemingly 175, 180 has been a top. Can't get through it. I think regional banks go lower from here.
10:28You know, it's interesting. Chris just mentioned seasonality gets a little bit better over the next few weeks. Think about this. When we got back from Labor Day, I think the consensus by most strategists, most investors, everyone we talked to was that September, you know, normally pretty bad, was going to be bad. And then every once in a while, you get one of those folks who pick their head up and say, well, I'm going the other way. I think it's going to be a rip-roaring. It's going to rip your face off. That's the pain trade higher. And look where we are on a month-to-day basis. I mean, the S &P is down nearly 4%.
10:51I mean, so it would take a miracle for it to close up, I think, on this month at this point. So I think sometimes it's interesting when we focus on being a little bit like going with the flow here. I really do think that, like, you know, I think that the highs are in. I think you sell rallies. And I think, Dan, to Guy's point, if we said 11 months and two weeks ago when the S &P bottomed on October 12th of last year, that one year later, Bank of America and Citigroup would be on the lows. I think we'd all be surprised by that. But we're nearly a year off the market bottom and the banks have simply not been involved.
11:23What does it mean? Well, it means that the market does not believe credit dynamics right now. And the banks are going to be in the epicenter. We know their balance sheets are fine. We know that some of the dynamic and the corporate balance sheets are largely fine. To some extent, we are worried about commercial property. We are worried about where the retail is. We have seen the cracks. But I agree. I mean, the fact that Citibank is through an SVB low here, I mean, that's tough. For more on rates, let's bring in New Edge Wealth Head of Fixed Income, Ben Emmons. Ben, great to have you with us. Hey, Melissa, it's great to be back.
11:57Hey, are we going to look back on this level of the 10 year yield and think this is pretty much the highs for this cycle? Well, I think we still have some to go here. You know, like if I was looking at technical levels today, if you take from, say, the 2007 peak to the bottom in 2021 and then back up, if you think of the retracement levels, so we've really broken through all of them. So technically speaking, you should actually make all the way back to the top. Now, there is some, I think, some tactical opportunity here. I was looking at TLT and VGLT. They're quite oversold now on short-term indicators.
12:29They've drawn down almost like 13%, 14 % from the peak in July. So that may be your tactical opportunity. But I think we have to reckon that a yield of 4.25 % was not really reflective of the economy. It may be a yield of 5.25%. And echoing to Tim and Chris's points, this is a supply-driven rally, but it's also about liquidity. We have quantitative tightening. So last week, for example, the Bank of England increased in quantitative tightening. So there's also a global story behind rates. So I think we may have a tactical short-term bounce here in VGLT or TLT, but it's really the upside of five and a quarter on the 10-year I think that we'll have to look at.
13:08So, I mean, not to play bond market too much, but the opportunity is there for yields to go slightly lower. But then that would, in theory, be the point where you would bet that yields would go much higher because you're actually seeing key resistance four and three quarters. Yeah, I think. So, Melissa, I think that this four and a half that was mentioned the other day was just not really holding here. There's too much pressure, you know, just simply by supply. They are very simplistic today with T-bill auctions. They don't actually never matter to markets, but they were not that well received.
13:39And I think that added to the pressure in yields this morning, we're getting a lot more supply this week. So I think it's more about 475 as a key resistance for this short-term technical buy opportunity. But then from there, we have to see how much it pulls back. You know, it depends on data and depends on inflation. if we don't pull back much, then it's really going to be a move towards five and a quarter. That does look like it. Hey, Ben, it's Tim. So how much of this, if at all, could be related to government shutdown dynamics? I've read your notes. They were fascinating. In fact, it's complex.
14:12You say maybe there's a short term even funding dynamic for the Treasury because they want to get through a difficult period. They want to have liquidity. T-bill market also. Look, in the short run, maybe they're trying to overfund in the T-bill market. as rates go higher, becomes a lot more expensive for them to finance a deficit that's getting bigger and bigger. And ultimately, they're going to have to lock in some higher rates out the curve. Attack this any way you want, because it's fascinating stuff. Yeah, for sure, Tim. And I think that, you know, how did this all start at this sell off in rates?
14:42If you go back to July when the Treasury met with this advisory committee, they said, OK, you know, you may go above that threshold of 20 percent debil issuance for a period of time. but then you should consider to move more issues out the curve because if you issue too much short-term, that deficit becomes very unstable. And so I think this is the dynamic that plays out today. Short-term funding for the government to keep open and just finance it with T-bills may not be enough. You have to actually push out issuance out the yield curve, and I think that's troubling the Treasury market currently.
15:15So you could expect to see more in the next quarter, the next refunding to see increased issuance for 10 and 30 year bonds. I think that's being priced in today, which we're seeing right now. That's interesting. But then you also throw in the possible dynamic that a government shutdown could lead buyers to buy sort of the safety of treasuries or the U.S. dollar, which is bizarre kind of thinking. But in the past, we have seen that happen. Yeah, it could be. Melissa, like I said, you know, Most of these shutdowns that have happened are short-term effects on the economy, almost like a weather effect, if you will.
15:53But it is an uncertainty moment, so it leads then to some level of flight to safety, if you will. And I think if you coincide with very short-term technical indicators and you're getting very oversold on ETFs like TTLT with a shutdown overhanging the markets, And that gives you, I guess, scope for this very short term technical rally that may be in the works. But I think the bigger picture is more about what Tim and I was just discussing. You're dealing with a deficit that's substantial and you're issuing it with too much short term paper. So if you have to get away from that, you've got to go out the U-curve in terms of issuance.
16:28That will continue, I think, be the pressure point for the Treasury market. Ben, good to see you. Thank you. Thank you, Melissa. Yeah, they're doing short term paper because they're clearly concerned, scared, I would say, what would happen if they tried to do a longer duration without question. So they're just trying to hopefully the bond market settles down and allows them to do something longer term. It's not happening. It's actually working against them, number one. And we talk about this without getting too much in the weeds, but don't discount what's going on in Japan. Dollar yen approaching 150 is a huge technical level.
16:59The Bank of Japan will jawbone. They won't be able to stop it. They've probably been selling treasuries. That's leading to this as well. Yeah, I think JCP yields have used this term. I think they could slingshot higher. I really do. I think there's dynamics also with the BOJ that at some point they're either going to lose more credibility or they're going to have to give in to the dynamics here. A lot of this, by the way, is also relatively good for commodities. What we're seeing here is that you almost have like this PPI dynamic, which is actually good for certain parts of the market. And it's actually not bad overall for the economy.
17:28I know it sounds crazy, not easy for the Fed, but we're seeing copper prices hold in. We're seeing iron ore. We're seeing dynamics around China. I think the resource names you continue to own. It's funny. You know, last week we heard from the Fed and there seems to be a massive disconnect between the voting members of the Fed and the voting public of the United States. If you think about higher for longer, it was really to deal with what they think is an economy that's staying afloat. And then if you look at these ABC polls as it relates to Biden's approval or therefore really disapproval rating, it's massive.
17:56And on the economy, it's really bad. And when the voting public is, you know, again, it's a poll. Who knows? But they are probably telling you how they feel about the economy right now. There seems to be a massive disconnect right now. And that's the thing that, I mean, I would probably go with the consumer. I'd probably go with the voters, how they're feeling. I think in the very short term on yields, look for classic signs of a blowoff. Volume, for example, we've been doing 40, 50 million shares a day on TLT. I'd say it's something in the blowoff categories, 80 or 90 million. We saw that near the 2020 lows there.
18:27So keep that in mind. It sounds silly to say, but what do we know historically? Bond yields go up until they don't, right? They go up until gravity hits them. I know we've got to go, but I mean, equities trade great on some level. If you consider the move we've had, I just want to say this. I want to say it from the seasonal aspect, and I think it's giving you a great opportunity on the setup here. Because we're not going up to five and a quarter on the 10-year in the short run. In other words, we've had a massive move, and I think equities have traded very resilient. Coming up, Apple's next move, the tech giant getting sliced over the last few months.
18:55And a few of our traders think the pain could continue. Why they are so sour on this name next. And talk about some home improvements. Williams-Sonoma surging as some big money flows into the retailer. So could this be the stock to really tie your portfolio together? We'll debate that when Fast Money returns.
19:15Welcome back to Fast Money. It's been a rough couple of months for Apple since hitting one all-time high after another. In June and July, the stock has pulled back more than 10 percent from its record. It's down more than 6 percent just in September alone, on pace for its worst month of the year. And a couple of our traders think this chart is getting worse before it gets better. Tim, you flagged this on the call today. Yeah, and I brought it up last block. So at the risk of being repetitive, I do think that the upside to Apple is capped here. It is about risk reward. And I look at the chart and I look at where that 150 level, that may be a little more aggressive.
19:45Remember, we traded to 176. It looked like it was going straight to 160. It bounced off that 50, held the 100, I should say. And I think that price action is impressive. I just think that when you consider some of the good news that's behind Apple and that the stock really is meandering at best, the dynamics around where I think the equal weighted and some of the technical aspects of the ETF world and how people are investing in the market, I actually think there's a lot more people focusing away from the mega cap stocks. So that is really my argument. The valuation is something that I think is easy to have a difficult time with at this point.
20:22And it just gets back to not getting away from you. You know, Tim, I think when you look at the chart, that 50-day moving average is resistance now. And I think it will be for the remainder of the year. 182, 183 is that level here. If you cut the rally in half that we've had this year, it gets you 160 on the chart. I think a 50 % retracement makes some sense there. But remember, when you look at this whole group of stocks, Apple, Google, Meta, Amazon, etc., there's about 350 analysts who cover all of them. There's only four cells on that whole complex of stocks. Isn't a lot of good news already in these things?
20:52Yeah, but in the context of a market that's expected to go lower, in the context of a consumer that is going to be weak, I mean, hasn't this stock really held up pretty well? Well, 170, so here we are. The prior all-time high was December of 2021, right around where we are now. So the good news is we're holding that level. The bad news is there's been no meaningful bounce since that China announcement a couple weeks ago. And if you said it a week or so ago, shadow ban in China, and this stock goes from 176 to 160 in a heartbeat. But here's, I mean, so defensive. Would you rather be, ooh. You did it.
Read the full transcript
21:24Would you rather. Apple or healthcare? It's funny. I was going to, would you rather. I was going to say, so to mega cap, I was going to say, so Google is expected on a gap basis to grow earnings next year 20 % and sales growth of 12%, okay? And Apple's trading 27 times its next year and expected to grow earnings maybe 7%, 8 % and on 6 % revenue growth. I'd much rather Google right here, right now. You know what I mean? You know your own rules. Yeah, yeah, yeah. But I thought that was more relevant. I don't even know what you asked me is the other thing. But maybe one of the other folks who are listening here, but I already made up my mind.
21:56So Google looks more attractive. That being said, at$160 ,000, and I've said it here too, and I think Tim even admits that$150 ,000 would probably be a pretty big overshoot. It would take a pretty big move to the downside or something very fundamental to the company. Maybe Guy didn't line up and get his USB-C titanium iPhone 15 Pro Max. Maybe that's something that didn't happen this past weekend. I mean, that's what they're pushing here, people, a titanium. Dan, I just don't think... USBC. I don't think we can just choose whatever narrative we want to shape the price action. At one point this year, these stocks were all offensive.
22:27Now we want to pretend they're defensive. I would pick health care over Apple here. I think there's a move. Oh, that was it? Thank you for answering my question. Sorry. I mean, it's like I didn't even come back from a sign. No, you're back. Welcome back, by the way. Thank you. There was a great scene in Pitch Perfect, the first one, where they're singing I am titanium early in the movie. Just saying. Dan, would you rather Google or Apple here? I'd rather not listen about Pitch Perfect. I tell you what, Google. Don't pretend you don't like that movie, Tim. Is that Cosner? Who is that? Who's in that?
22:57I don't know. Cosner's not in Pitch Perfect. It's a baseball movie. It's the acapella stuff. It's not about baseball. I got no time for that movie. I've got more time for Google over Apple here. I'm long Google. Healthcare or Apple, though? Oh. Healthcare. Healthcare. And healthcare has been a tough place to be, and I realize the headwinds, and we've got all the politics ahead of healthcare. We've had a lot of politics over the summer. Healthcare. All right. There's a lot more fast funding to come. Here's what's coming up next. Out of the frying pan and into your portfolio, Williams-Sonoma surging as it gets a vote of confidence from one big investor.
23:31So make yourself at home. The traders are digging into this one next. Plus, the weight loss drug boom isn't just boosting pharma stocks. The manufacturing name that could see some outsized gains, thanks to the population slimming down. That's ahead. You're watching Fast Money, live from the NASDAQ market site in Times Square. We're back right after this.
24:02Welcome back to Fast Money, a solid home improvement project for shares of Williams-Sonoma today. Green equity investors, an arm of investment firm Leonard Green, revealed a 5 % stake in the company. The position is passive, according to the filing, but shares of the home goods retailer did hit their highest level in just over a year. Williams-Sonoma, what are they known for, guys? Well, let's not do that. Well, what are they known for, Tim? It's maybe potpourri, possibly scented candles. Dutch ovens. Dutch ovens. Okay, so. Anyway, what do you make of this? We did it. We did it. If Carter was here, Chris is here, he would say, you know what?
24:38We've actually entered a bearish to bullish reversal on the chart going back from its all-time high in November of 2021. It's been a series of lower highs and lower lows. That has changed over the last month and a half, two months. Valuation, reasonable, 11 times next year's numbers. Trades effectively one times revenue. It's a great company with a great story. The question is, can it hold up in this environment on the high end? I think it can. I think the stock can go higher. You know, Guy, I would just add, it's certainly a good chart. It has those characteristics. But we need to be mindful.
25:07It's the best chart in a bad group. I'd rather own the worst chart in a good group, where if something goes wrong here, you don't get bailed out with the group behind you. So I don't think it can be a full position here, given the group dynamics. The news, as the headline hits, though, is obviously very bullish for Williams-Sonoma, because Leonard Green is known to be very smart in the consumer retail space. It's almost a pat on the back, showing the 5 % position. It's a decent endorsement, also just because it says a lot about the strength of the e-commerce business that they've built. It says a lot about the strength of the management team.
25:39So I like it. I like the multiple. I think it's probably not a place where he's making a big move here. Restoration hardware is another name I just want to throw in there because this is a name that I've been trading and so far pretty well. And I hate to sound like real happy here. What I'm saying is that stock's gone from three ninety down to about two sixty. And this is about where I put it on the first place. I think it is worth looking at. And I do think that the news we got out of this earnings cycle was not terribly good. Chris is right, though. These names, I think, still have some headwinds.
26:10I'm not sure you have to do it right now. What are you laughing at? I'm just saying, you know, I can smirk. No, because I was just thinking about Dutch Ovens and how much we're going for them. You were thinking about how well he's trading. That's what you were thinking about. Self-congratulatory. I get it. By the way, Anna Kendrick, she watches Fast Money. She's mad at you because you didn't know what the movie was. You might want to apologize. Sorry, Anna. It's great that you watch our show, though. Thank you. On that note, coming up, one manufacturing name could be beefing up as others are slimming down.
26:40The CEO will join us next to lay out how the weight loss drug boom is boosting his business. Plus a massive AI bet. Amazon plugging as much as$4 billion into one tech startup. We'll chat about those details and more when Fast Money returns. Missed a moment of fast? Catch us anytime on the go. Follow the Fast Money podcast. We're back right after this.
27:08Welcome back to Fast Money Stocks, snapping a four-day losing streak to kick off the last week of September and Q3. The Dow at 43 points, the S &P and Nasdaq each climbing four-tenths of a percent. And Costco getting in on this health care space. The bulk retailer now offering members access to medical care through Sesame, a direct-to-consumer health care marketplace. Costco members can receive virtual primary care visits for as low as$29. The move comes as companies like Amazon, CBS, and Walgreens also look to deepen their footprint in health care. Meantime, the weight loss drug boom isn't just a benefit to big pharma.
27:41It might be tipping the scale in favor of manufacturing company Jacobs Solutions. Its life sciences business has longstanding ties to Eli Lilly and Novo Nordisk. And Barclays sees significant growth for Jacobs as it holds a leading market share with the drug makers. Joining us here on set is Jacobs Solutions CEO Bob Pregata. Bob, great to have you with us. Thank you for flying in and seeing us here on set. Melissa, thanks for having me. When we say dominant market share, it's 60 % in your life sciences. It is. We entered the life sciences world almost 75 years ago. Our founder, Dr. Jacobs, actually right here in Brooklyn, was a Merck employee and left Merck to start his own engineering firm.
28:22And Merck has been a longstanding client since then. And we've diversified in the life sciences ward amongst other infrastructure and in other areas as well over the course of that period of time. So we mentioned your longstanding ties to Novo as well as Eli Lilly, the two manufacturers of GLP-1s, which are the active ingredient in these weight loss drugs. And so, you know, how how are you thinking about what that adds to your pipeline, which had been at about 27 billion at the end of fiscal full year 2022? Correct. Correct. So if you think about our life sciences business, just in the last five years, driven by two other verticals, oncology drugs as well as Alzheimer's and all the advancements that are happening there.
29:05We've doubled the size of our business in the last five years, along with chip manufacturing as well. So that business has been on a growth train driven by technology advancements. And those technology advancements now have entered the world of diabetes with some beneficial other effects with regards to weight loss. And so we're seeing that in real time. So you mentioned, for instance, cancer drugs as being a driver. But what percentage of the growth do you think can be attributable to obesity and the diabetes or this category of drug? Moving forward, I think it's going to be likely a majority.
29:43We'll continue to see. Today, we're a$15 billion company in sales, 60 ,000 employees across 40 countries. Our advanced manufacturing work is about$2.5 billion of that. We could potentially double that in the next three to four years as a result of these megatrends that are happening within novel therapies. So how do you forecast out? I mean, you said you think it's going to be the majority of growth going forward. But how do you think about the expansion opportunity that you have in front of you when you hear about the miracle possibilities that these drugs can lead to as being a treatment for addictions, to reduce cardiac events, to eliminate sleep apnea as a treatment for Alzheimer's?
30:26I mean, the list goes on and on in terms of the possible applications. How do you think about that growth translating into your business? Clearly, we get we get excited. We get we get excited. I think we wouldn't be proper for us to be in the business if we didn't get excited. But the other component is the complexity in the facilities really is the unique and dynamic part of our business. And so that science-based technical consulting that we have within the life sciences space is driving innovation and delivery as well. Because I think I just saw an interview that David Ricks gave a couple of weeks ago on Squawk Box.
31:02capacity was probably mentioned several times in that interview and when you hear capacity and you hear speed that's where jacobs comes to play how quickly can you help get a manufacturing facility uh up and running i for instance was in denmark last week saw the ground at novo nordus being broken at their newest facility i'm not saying that there's but i'm just curious how quickly could that be up and running? These normally take, if I were to go back five years, then talk about COVID and what happened there, and then now, five years ago, that would have been five years in order to go from groundbreaking all the way through a validated facility.
31:42COVID taught us a lot of lessons, and it's go as fast as you can, because the entire world is dependent on this facility producing vaccines. And so today, we're probably in that two and a half to three year period. Wow. And then after that two-year period and that plant is up and running, is your relationship with that particular plant over or is there recurring revenue or recurring business associated with that plant? There is recurring business that goes on with that plant. You're constantly making upgrades, looking at innovations that are happening with manufacturing technologies. So there'll be ongoing work on that facility.
32:15Big backlog, almost$30 billion, I think up almost 2.5 % year over year, big margins. How important are government contracts? I saw an EPA contract in early August, I think? Government contracts are very important. And what we're seeing with these legislative actions that have happened and kind of transcending beyond life sciences with the IJA Act, as well as CHIPs Act, both here and in Europe and in the IRA, those contracts are driving our business. I'm sorry, those acts are driving our business and will be for the foreseeable future. So nearshoring, basically. I mean, When a chip plant says we're going to move here or we're going to open a new chip plant here because of the CHIPS Act, that's where you benefit.
32:58You have 60 percent of the semiconductor market as well. We do. We do. So we do benefit. And I would say the nearshoeing component or the restoring component is a big piece. The other big piece around semiconductor is how companies like a large American semiconductor manufacturer is redefining their own business model. So going from integrated device manufacturing to being both a foundry as well as an IDM is changing their business, which is adding capacity both in the States as well as in Europe. Europe also passed a CHIPS Act as well. That's driving our business. Bob, we've seen over the last several years how tight labor has been and what that's done with wages.
33:40Is that easing? Are you seeing any improvement there? I'd say in the field that is a topic. And I think that more innovation and delivery, we address those productivity enhancement items in order to address that issue. Within Jacobs, we've got a unique opportunity because we're a global company. And so when a large chip manufacturer comes to us or a life sciences or biotech company comes to us and says, we need five of these as fast as you can go in five years, what we do is we use our global delivery model. And so if you look at what we have in India, what we have in Philippines, and this isn't offshore engineering.
34:20This is the highest talent in the world coming together in integrated teams and delivering locally for these really market-driven needs. How recession-proof is the two big areas of your business, the life sciences as well as the semiconductors? I don't know if anything is completely immune to a recession, but pretty resilient, I would say, because of the drivers. I mean, these drivers are human lives, you know, the ubiquitous world of everything that needs a chip. And that's not stopping. Bob, thanks so much for coming in. We hope you'll come back to our show soon. Thank you. Thanks for having me.
34:57Bob Bregada. Jacobs. We do these 13 Fs we talk about. You know, you should look at these. We should probably look at them a little closer. But third point in August announced they had increased their stake by almost 700 percent from a couple hundred thousand shares to 1.4 million shares. I won't bring the guests back, as you say, but there's always M &A around this name as well. The stock trades well, and it doesn't trade at a huge premium. The sum of the parts dynamic of how I think the analyst community is valuing the stock based upon the different pieces of the business and the spinoff opportunities is really what's fascinating and part of what's driving a lot of upgrades right now.
35:29How does the chart look, Chris? It's a good chart. It's in a good group. It's in an uptrend when we're starved to find stocks and uptrends. Yeah, those two drivers. I mean, think about it. We spent a lot of time over the course of 2023 talking about them. And you think about that backlog that Guy talked about. You think of their market share in both of those industries. I think they kind of are recession proof. And, you know, I mean, semiconductors like to spend themselves out of a recession. And then if you think about how the life sciences business, this is a mega trend that's going to go on for at least a decade.
35:58So to me, it's a pretty interesting setup. Coming up, Alexa might be getting some company on Amazon's AI shelf. the e-commerce giant, siphoning up the arms race with$4 billion investment. The details straight ahead. And CNBC is celebrating Hispanic heritage. Here's the co-founder of Gold Belly.
36:16My parents raised me to believe that I can do anything. I came to the U.S. I went to college here. I pursued a lot of different opportunities before launching my company, Gold Belly, successfully. And I just know that this is an American dream for my parents, and it makes me really proud to have been able to deliver that.
36:45Welcome back to Fast Money. Amazon pressing its bets on AI, the e-commerce giant investing up to$4 billion in AI startup Anthropic, hoping to use a company's technology and its products and even help develop custom chips for Amazon. Dan? Good news. I mean, you know, it's interesting. The stock sold off 10 percent in a straight line. And then you go and over the weekend you put out a press release like this, one in the quarter. I mean, listen, this is a company where it was founded by ex-OpenAI folks. You know what I mean? Like so like they got the real deal. They're working on the stuff. There's going to be lots of competition in these sorts of spaces in a way.
37:19And when you think about AWS and you think about this platform that exists to kind of service a whole host of different sorts of companies, this makes sense. One and a quarter billion is probably a rounding error. I do think it's interesting that, you know, ultimately Microsoft got up to about a$10 billion number with OpenAI. It may end up being a great investment and it may end up powering a whole host of new services for AWS, which, you know, went through this massive deceleration of growth and they've had a lot of competition. So to me, it all makes sense. The agreement sort of reminded me of the Microsoft OpenAI in terms of a small amount up front, the use of the cloud services, right?
37:55So they get business in return in a way. Yeah, it makes sense. And you get a pop in the stock. However, and Chris can speak to this. Last August, the stock traded up to 145 and failed and sold off dramatically. Look at where we just traded up to and seemingly failed again. We're trading 132 now. What was 145 to Dan's point a couple of weeks ago? So I think you have a short term double top here. I wouldn't touch it. I think the underwhelming response from the stock today is a sign of how the tone of this market has changed over the last two or three months. If this was in May or June, the stock would have been at more than two bucks.
38:25There's a gap around 136, 137 from the breakdown maybe four sessions ago. I think it can bounce to that, but I'm a seller up there, much like the big names. I think this one is topped for the year. I actually think it's a no-brainer for Amazon. And if you think about the public cloud and what AI is doing, they have to be here. They have to make this investment. This is chump change. Coming up, it's a bird. It's a plane. Nope, it's Chris Verone. Since he's here for the hour, we've got to put him to work, set him off the chart, find out what he's watching next. Stick around. More Fast Money right after this.
38:57Welcome back to Fast Money. Semis may have cooled off lately, but the group is still up more than 40 percent this year. Chris, though, says there could be even more trouble brewing under the surface. You're going to go off the charts. Chris, what are you looking at? Yeah, you know, I think what's interesting, this has been a very vaunted group all year, but I think it's really underwhelming under the surface. We'll start with the biggest and most important name. NVIDIA, I think it's top for the year. There's a lot of resistance now in this 450 neighborhood, roughly where it broke down from a couple weeks ago.
39:25The 200-a-moving average is still 100 points away at 340, and there's a massive gap on the chart. I think as we've seen time and time again this year, there are no sacred stocks in this business. The untouchables have all been touched. I don't think NVIDIA will be any different. And when you kind of go stock by stock in the group, what becomes clearer and clearer is how weak the semis are under the surface. TXN would be an example. It broke down this week, really making 52-week lows there. If you look at names like Infineon or ASML or Taiwan Semi, these are on the 52-week low list, not the 52-week high list.
39:59And it speaks to the broader point of the internal deterioration we've seen in semis. And I think one of the more powerful charts, if you look at the advanced decline line of the S &P Semi Index, so there's 50 stocks in this index, the advanced decline line is on the lows. So I recognize the index is still up 30 or 40 percent this year. But the fact that you have the AD line roughly making new lows here, I think, speaks to just how weak this group is under the surface. They're short-term oversold. I can see them bouncing here in the near term. Fade those rallies. I think they've topped for the year.
40:31Would you shorten Vidya again, Dan? Yeah, maybe. Let's see if it gets a little bit of a bounce. I mean, listen, the story for the rest of the year is going to be the deceleration of that growth, right? And so if there's any hiccups in the adoption of some of these products or whatever or anything geopolitical or whatever, I mean, it's great. It's been a fantastic story. I was very, very wrong. I was like, I'm off the flame in this sort of thing. But again, I think this story, I think it's about as good as it gets right here. Well, the move that NVIDIA made on May 24th, 25th, whatever it was, and what it meant for the semiconductor, the SOX, whatever you're following, SMH, is the question.
41:04Because we've been fighting. It hasn't gone past there. That was the relative high. In fact, it took out the high of Dec 21, and it's been making lower highs ever since. So I agree with the analysis, Chris. I agree that leadership was critical for the markets from that October. That CPI low of last year is really when all this started to move. It hasn't fallen apart as people. It would have been so easy to say, boy, that that NVIDIA move was so overdone. And actually, I think it's been I think it's been somewhat resilient. But I'm not going to I'm not going to fight that view. I agree. I think we've had trouble making relative highs.
41:38And therefore, the Q's are having trouble making relative highs as well. And I think until they do, I think markets look toppy. I think the great paradox here is you talk about the 9 % CPI print of last July. It was the 3 % CPI print of this July where leadership really changed, away from the cues, away from discretionary, back to energy. Markets love paradox, and it's been exhibit A. Taiwan Semi has been rolling over now since June. AMD below 100 for the first time in a while. On that SMH chart, which we talked about at the top of the show, that is a massive double top without question. It seemingly will be intact for quite some time.
42:15So this ties perfectly back to the top of the show. We just put a bow on it. We just, you just did. I mean, you look often at semiconductors as sort of being that cyclical indicator. It's one of the, you know, you turn on your screens in the morning, there's a handful of canaries you look at. I mean, that has to be one of them. All right. Up next, final trades.
42:44Time for the final trade. Tim Seymour. Yeah, well, if you think about defensive sectors, I do think Altria belongs in its own sector. And I think you've rewritten a lot of the bad news in that stock. M.O. Chris Verone. There's some life and health care along Amgen, AMG, and Porkenup. Good to have you, Chris. Dan? I'm going to play your game. Which one? XLV. Oh. Finally. We're looking okay. We only took 58 minutes of the show. Sorry about that. Guy. Yeah, there might be life in health care, but there's no life at Shea. I mean, that place has been empty, Tim, since August, as you know. Well, I mean, things aren't going too well in the Bronx either, my man.
43:21It's coming to an end, which is why. Get some football tonight, Mel. Sink some Icapella. And you were talking about the Bengals. Boomer Sighs, and congratulations. Ring of Honor. You mentioned that earlier. He watches the show. He does. Ring, R-A-G. Thank you for watching Fast Money. We'll see you back here tomorrow at 5 for more Fast. Meantime, do not go anywhere. Mad Money with Jim Cramer starts right now.
44:06expression of an opinion. Such opinions are based upon information the Fast Money participants consider reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. To view the full Fast Money Disclaimer, please visit cnbc.com forward slash Fast Money Disclaimer.
From the publisher
The yield on 10-year treasurys crossed the 4.5% mark for the first time since October 2007, but it's the benchmark’s relationship with the 2 year that caught the attention of one of our traders. Why the steeply steepening yield curve could be setting up equities for a problem period. Plus manufacturing giant Jacobs Solutions counts Eli Lilly and Novo Nordisk as two of its biggest customers. How the company is benefiting from the surging demand for weight-loss drugs.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
